NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Patrick KellyEVP CFO and Treasurer2026-03-075,904$9.98
$58.92kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0322,429$9.49
$212.85kSell
Mark J. CaseyEVP Chief Legal Officer2026-03-0311,378$9.49
$107.98kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
John C. JacobsPresident and CEO2026-03-0369,288$9.49
$657.54kSell
James Patrick KellyEVP CFO and Treasurer2026-03-0320,850$9.49
$197.87kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0110,969$10.14
$111.23kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell

1 of 2

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cadila Pharmaceuticals Ltd5.76%9,500,000$96.05MInsider
James B. 1. Tananbaum3.80%6,268,455$63.37MInsider
Sj Strategic Investments LLC2.43%4,001,500$40.46MInsider
Thomas P. Monath1.96%3,232,366$32.68MInsider
Rajiv I. Modi1.52%2,500,000$25.28MInsider
Nelson M. Sims0.17%275,000$2.78MInsider
John C. Jacobs0.14%225,680$2.28MInsider
Denis M. Odonnell0.13%221,495$2.24MInsider
Gail Boudreaux0.12%200,000$2.02MInsider
Elaine Ohara0.08%134,642$1.36MInsider

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX0.07%17.14%Net Selling
KLRA0.09%85.25%Net Buying
ABSI0.09%29.45%Net BuyingNet Selling
IMCR0.10%4.27%Net Selling
TSHA0.09%9.67%Net SellingNet Selling

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 0.07% institutional shareholders, 17.14% Novavax insiders, and 82.79% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.76% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $96.05M.

If you're new to stock investing, here's how to buy Novavax stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.